Scrofula • Helps as a supportive drug in managing scrofula.
Biocombination No. 22
- Additional information
- For Information of doctors
- Safety Guidelines
- Important info
- Reviews 0
20 g, 550 g
Indications: Both dry and suppurating scrofulous abscesses. Almost all symptoms of the disease are covered.
Scrofulosis (Scrofula) is a morbid constitutional state of system characterised by indolent glandular tumours that suppurate slowly, heal with difficulty and leave scars.
A well defined skin condition of subcutaneous nodules which gradually enlarge, degenerate, ulcerate and terminate cutaneously. Scrofula as a typical scar tissue is known as Scrofuloderma, lesions commonly occurring about the face, neck through lymph glands. These conditions are also covered by this medicine.
Composition: Calcarea phosphorica 3x, Ferrum phosphoricum 3x, Kalium muriaticum 3x, Silicea 6x in equal proportion.
Proven indications of the ingredients within the claimed sphere of action:
Calcarea phosphorica: Itis indicated for scrophulosis, chlorosis and phthisis covering tubercular glandular enlargements.
Ferrum phosphoricum: Ithas been used in acute exacerbation of tuberculosis, inflammed throat, ulcerated sore throat and restlessness with fever.
Kalium muriaticum: Itis indicated for enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles and bursitis. Along with Calcarea phosphorica is covers disturbing symptoms of scrophulosis.
Silicea: Itis used for scrofulous children. It controls abscesses, organic changes and suppurative processes.
Contra-indication: Nil. Dosage: Adults 4 tablets, children 2 tablets, at a time, four times a day at intervals of three hours. Presentation: Tablets of 100 mg. in bottles of 20g.
Alcohol: There is no reported safety concern if it is taken with alcohol.
Pregnancy: It is safe to take during pregnancy.
Driving: It is safe to use during driving.
Breastfeeding/Lactation: It can be used while breastfeeding.
Kidney: There is no known contraindication with kidney diseases.
Sugar: It does not affect blood sugar levels.
Immunity: It will not affect the immunity of an individual.
Liver: It is safe for the liver.
High blood pressure/Hypertension: It is safe to use in patients with hypertension.
Low blood pressure: It will not lower the blood pressure.
Heart: It does not contain any ingredient which will affect the heart.
Mentally retarded: There is no known contraindication with mentally retarded persons.
Post covid impacts: There is no known contraindication with post covid impacts.
Diarrhea: It will not cause any diarrhea.
Gastric: There are no known effects on the gastrointestinal system.
Empty stomach: It is preferably to be taken after a meal.
Skin allergy: There is no skin allergy when using Biocombination No.22.
Habit: It is not a habit-forming product.
Overdose: In case of overdose, drinks lots of water or consult a physician.
Storage: It has to be stored in a cool dark place, away from sunlight and strong-smelling substances.
Temperature: The temperature should be 25 degrees centigrade.
Biocombination No.22 is the combination of biochemic medicines which is indicated in suppurating scrofulous abscesses, and is composed of Calcarea phosphorica, Ferrum phosphoricum, Kali muriaticum and Silicea in equal proportion.
Yes, it is suitable for children.
It has to be taken as long as the symptoms are better or till the improvement sets in or otherwise as prescribed by the physician.
Yes, it is safe to take Biocombination No.22.
No, it does not cause any dryness in the mouth.
Biocombination No.22 is found useful in dry and suppurating scrofulous abscesses. The term scrofulous means it is a morbid state characterized by indolent glandular tumors that suppurate slowly, heal with difficulty and leave scars. Calcarea phosphorica is indicated in scrofulosis, chlorosis, and phthisis covering tubercular glandular enlargements. Ferrum phosphoricum is used in acute exacerbation of tuberculosis, inflamed throat, ulcerated sore throat, and restlessness with fever. Kali muriaticum is indicated in the enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles, and bursitis. Silicea is indicated in scrofulous children and controls abscesses, organic changes, and suppurative processes.
It should be taken as 4 tablets for adults, and 2 tablets for children, at a time, four times a day at intervals of three hours or as prescribed by the physician.
Biocombination No.22 is the combination of four biochemic remedies such as Calcarea phosphorica, Ferrum phosphoricum, Kali muriaticum, and Silicea. Calcarea phosphorica is indicated in scrofulosis, chlorosis, and phthisis, a tendency to perspiration and glandular enlargements. Ferrum phosphoricum is used in acute exacerbation of tuberculosis, inflamed throat, ulcerated sore throat, and restlessness with fever. Kali muriaticum is indicated in the enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles, and bursitis. Silicea is indicated in scrofulous children and controls abscesses, organic changes, and suppurative processes.
No side effects have been reported so far.
No precautions are necessary.
It is not a problem if you skip a few doses, but don’t take double doses.
Thyroidinum 1X, Alumen LATT, Thyroidinum 3X, Calcarea fluorica, Silicea.
Each tablet of Biocombination No.22 contains Calcarea phosphorica 3X 25mg, Ferrum phosphoricum 3X 25mg, Kali muriaticum 3X 25mg, and Silicea 6X 25mg.
Manufactured in India by Dr. Willmar Schwabe India Pvt. Ltd. A-36, Sector-60, Uttar Pradesh, Noida – 201304.
Country of Origin: India.
Registered office Address: Dr. Willmar Schwabe India Pvt. Ltd. H-36, Green Park Extension, New Delhi, Pin: 110016.
Expiry: 5 years for the date of manufacturing.